In the last trading session, 1.15 million shares of the Precigen Inc (NASDAQ:PGEN) were traded, and its beta was 1.64. Most recently the company’s share price was $1.11, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $325.08M. PGEN currently trades at a discount to its 52-week high of $1.93, offering almost -73.87% off that amount. The share price’s 52-week low was $0.65, which indicates that the current value has risen by an impressive 41.44% since then. We note from Precigen Inc’s average daily trading volume that its 10-day average is 1.87 million shares, with the 3-month average coming to 1.34 million.
Precigen Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended PGEN as a Hold, whereas 2 deemed it a Buy, and 1 rated it as Underweight.
Precigen Inc (NASDAQ:PGEN) trade information
The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.1600 on recent trading dayincreased the stock’s daily price by 4.31%. The company’s shares are currently down -0.89% year-to-date, but still down -5.53% over the last five days. On the other hand, Precigen Inc (NASDAQ:PGEN) is 64.79% up in the 30-day period. We can see from the shorts that 15.32 million shares have been sold at a short interest cover period of 24.02 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 81.5% from its current value. Analyst projections state that PGEN is forecast to be at a low of $6 and a high of $6.
Precigen Inc (PGEN) estimates and forecasts
Precigen Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -33.13 percent over the past six months and at a -31.43% annual growth rate that is well below the industry average of 16.50%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 36.94%.
PGEN Dividends
Precigen Inc’s next quarterly earnings report is expected to be released in February.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.17% of Precigen Inc shares, and 63.83% of them are in the hands of institutional investors. The stock currently has a share float of 71.06%. Precigen Inc stock is held by 180.0 institutions, with PATIENT CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 7.2926% of the shares, which is about 18.17 million shares worth $28.72 million.
BLACKROCK INC., with 4.1116% or 10.25 million shares worth $16.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 14.4 shares worth $15.98 million, making up 4.92% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 5.45 shares worth around $6.05 million, which represents about 1.86% of the total shares outstanding.
